Lung cancer cells are radiosensitized by pharmacologic ATM kinase inhibitors in tissue culture [8–10], and it is widely believed that ATM kinase inhibitors will be well-tolerated in the clinic as ATM is not an essential protein [7, 11]. This evidence concerns the gene ATM and lung carcinoma.